Feasibility and safety of liver resection for huge hepatocellular carcinoma in cirrhotics


  • Ashraf Mohammad El-Badry Department of Surgery, Sohag University Hospital, Faculty of Medicine, Sohag University, Sohag, Egypt
  • Ahmed Abdelkahaar Aldardeer Department of Surgery, Sohag University Hospital, Faculty of Medicine, Sohag University, Sohag, Egypt




Huge HCC, Liver resection, Cirrhosis


Background: With the current high incidence of hepatocellular carcinoma (HCC), more patients even with large and huge HCC are considered for liver resection.

Methods: Medical records of consecutive adult cirrhotic patients who underwent partial hepatectomy for huge HCC (≥10 cm, huge HCC group) versus small HCC (<5 cm, small HCC group) at Sohag university hospital (January 2016 to December 2020) were analyzed. Both groups were compared regarding postoperative morbidity and risk of mortality following post hepatectomy liver failure (PHLF) as defined by the 50-50 criteria (50% mortality occurs among patients who developed increased plasma bilirubin >50 μml/l and reduced prothrombin activity <50% on postoperative day 5 (POD-5).

Results: Thirty two patients were enrolled (16 per group), with median age of 56 (range 38-81) years, 22 were males. In correlation with resection of more liver segments in the huge HCC group, post hepatectomy alteration of liver functions (bilirubin rise and reduction of albumin and prothrombin concentration) was significantly pronounced among patients who had resection for huge compared with small HCC (p<0.05). Huge HCC group exhibited significantly worse postoperative complication score (p< 0.05) and needed significantly prologed periods of hospital stay (p<0.05). Concurrent persistence of PHLF and thrombocytopenia until POD-5 occurred in 3 patients (2 with huge HCC and 1 with small HCC). Among those patients, only one from huge HCC group died (mortality 6%) postoperatively.

Conclusions: Liver resection provides safe and effective treatment strategy for carefully selected cirrhotic patients with huge HCC.



Koulouris A, Tsagkaris C, Spyrou V, Pappa E, Troullinou A, Nikolaou M. Hepatocellular carcinoma: an overview of the changing landscape of treatment options. J Hepatocell Carcinoma. 2021;8:387-401.

Omar A, Abou-Alfa GK, Khairy A, Omar H. Risk factors for developing hepatocellular carcinoma in Egypt. Chin Clin Oncol. 2013;2(4):43.

Elbahrawy A, Ibrahim MK, Eliwa A, Alboraie M, Madian A, Aly HH. Current situation of viral hepatitis in Egypt. Microbiol Immunol. 2021.

Kiseleva YV, Antonyan SZ, Zharikova TS, Tupikin KA, Kalinin DV, Zharikov YO. Molecular pathways of liver regeneration: a comprehensive review. World J Hepatol. 2021;13(3):270-90.

Ishikawa J, Takeo M, Iwadate A, Koya J, Kihira M, Oshima M, et al. Mechanical homeostasis of liver sinusoid is involved in the initiation and termination of liver regeneration. Commun Biol. 2021;4(1):409.

Tsomaia K, Patarashvili L, Karumidze N, Bebiashvili I, Azmaipharashvili E, Modebadze I, et al. Liver structural transformation after partial hepatectomy and repeated partial hepatectomy in rats: a renewed view on liver regeneration. World J Gastroenterol. 2020;26(27):3899-916.

Aierken Y, Kong L, Li B, Liu X, Lu S, Yang J. Liver fibrosis is a major risk factor for liver regeneration: a comparison between healthy and fibrotic liver. Medicine (Baltimore). 2020;99(22):20003.

Lin XJ, Yang J, Chen XB, Zhang M, Xu MQ. The critical value of remnant liver volume-to-body weight ratio to estimate posthepatectomy liver failure in cirrhotic patients. J Surg Res. 2014;188:489-95.

Aydın MM, Akçalı KC. Liver fibrosis. Turk J Gastroenterol. 2018;29(1):14-21.

Chen ZL, Zhang C, Liang L, Wu H, Zhang W, Zeng Y, et al. Major hepatectomy in elderly patients with large hepatocellular carcinoma: a multicenter retrospective observational study. Cancer Manag Res. 2020;12:5607-18.

Hsueh K, Lee T, Kor C, Chen T, Chang T, Yang S, et al. The role of liver transplantation or resection for patients with early hepatocellular carcinoma. Tumour Biol. 2016;37(3):4193-201.

Lerut J, Foguenne M, Lai Q. Hepatocellular cancer selection systems and liver transplantation: from the tower of babel to an ideal comprehensive score. Update Surg. 2021:294.

Ju MR, Yopp AC. Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience. Ann Gastroenterol Surg. 2020;4(3):208-15.

Allaire M, Goumard C, Lim C, Cleach AL, Wagner M, Scatton O. New frontiers in liver resection for hepatocellular carcinoma. JHEP Rep. 2020;2(4):100134.

Clavien PA, Barkun J, Oliveira MLD, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187-96.

Ali MM, El-Badry AM. Influence of combined mechanical-chemical versus mechanical bowel preparation on anastomotic leak and surgical site infections after elective resection of left colon cancer. Int Surg J. 2020;7:3192-7.

Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The ‘50-50 criteria’ on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242(6):824-8.

Ray S, Mehta NN, Golhar A, Nundy S. Post hepatectomy liver failure: a comprehensive review of current concepts and controversies. Ann Med Surg. 2018;34:4-10.

Ferrante ND, Pillai A, Singal AG. Update on the diagnosis and treatment of hepatocellular carcinoma. Gastroenterol Hepatol. 2020;16(10):506-16.

Doğan SM, Kutlutürk K. Living donor versus deceased donor liver transplantation for HCC. J Gastrointest Cancer. 2020;51(4):1104-6.

Sapisochin G, Bruix J. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol. 2017;14(4):203-17.

Makary MS, Khandpur U, Cloyd JM, Mumtaz K, Dowell JD. Locoregional therapy approaches for hepatocellular carcinoma: recent advances and management strategies. Cancer. 2020;12(7):1914.

Chang Y, Jeong SW, Young J, Kim YJ. Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma. Int J Mol Sci. 2020;21(21):8165.

Kutlu R, Karatoprak S. Radioembolization for hepatocellular carcinoma in downstaging and bridging for liver transplantation. J Gastrointest Cancer. 2020;51(4):1157-64.

Asemota J, Saleh M, Igbinovia O, Burns D. A concise review on current trends in imaging and surgical management of hepatocellular carcinoma. Cureus. 2020;12(7):9191.

Bogdanovic A, Bulajic P, Masulovic D, Bidzic N, Zivanovic M, Galun D. Liver resection versus transarterial chemoembolization for huge hepatocellular carcinoma: a propensity score matched analysis. Sci Rep. 2021;11:4493.

Lee CW, Yu M, Wang C, Lee W, Tsai H, Kuan F, et al. Liver resection for hepatocellular carcinoma larger than 10 cm: a multi-institution long-term observational study. World J Gastrointest Surg. 2021;13(5):476-92.

Zhuang H, Zhou Z, Ma Z, Huang S, Gong Y, Zhang Z, et al. Prognostic stratification based on a novel nomogram for solitary large hepatocellular carcinoma after curative resection. Front Oncol. 2020;10:556489.

Wei CY, Chen P, Chau G, Lee R, Chen P, Huo T, et al. Comparison of prognosis between surgical resection and transarterial chemoembolization for patients with solitary huge hepatocellular carcinoma. Ann Transl Med. 2020;8(5):238.

Zhu SL, Zhong J, Ke Y, Ma L, You X, Li L. Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma. World J Gastroenterol. 2015;21(32):9630-7.

Michalopoulos GK, Bhushan B. Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol. 2021;18(1):40-55.

Sigal SH, Sherman Z, Jesudian A. Clinical implications of thrombocytopenia for the cirrhotic patient. Hepatic Med Evid Res. 2020;12:49-60.

Zhang Z, Zhang Y, Wang W, Hua Y, Liu L, Shen S, et al. Thrombocytopenia and the outcomes of hepatectomy for hepatocellular carcinoma: a meta-analysis. J Surg Res. 2017;210:99-107.

Wang HQ, Yang J, Yang JY, Wang WT, Yan LN. Low immediate postoperative platelet count is associated with hepatic insufficiency after hepatectomy. World J Gastroenterol. 2014;20:11871-7.

Wakayama K, et al. Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection. J Surg Oncol. 2017;115(3):324-9.

Mussbacher M, Brunnthaler L, Panhuber A, Starlinger P, Assinger A. Till death do us part-the multifaceted role of platelets in liver diseases. Int J Mol Sci. 2021;22(6):3113.






Original Research Articles